| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.74 | 0.006 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |